Biomarkers in Mild Stages of Alzheimer’s disease: Utility in clinical practice and their relation with nutritional and lifestyle factors
| Autor: | Leandro Lon, Patricio Perez Leguizamon, Jorge Santiago López Camelo, Veronica Guelar, Fernando E. Taragano, Silvina L Heisecke, Cecilia Serrano, Carol Dillon, Diego Castro |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Alternative medicine MEDLINE Medicine (miscellaneous) lcsh:TX341-641 Disease Clinical practice Biochemistry 03 medical and health sciences 0302 clinical medicine Utility Early treatment medicine Dementia Intensive care medicine Nutritional and Lifestyle Factors lcsh:R5-920 Nutrition and Dietetics business.industry medicine.disease 030227 psychiatry Clinical Practice Clinical trial Clinical research Physical therapy Biomarker (medicine) business lcsh:Medicine (General) Alzheimer’s disease lcsh:Nutrition. Foods and food supply 030217 neurology & neurosurgery Biomarkers Food Science |
| Zdroj: | Functional Foods in Health and Disease, Vol 6, Iss 10, Pp 627-649 (2016) |
| ISSN: | 2160-3855 |
| Popis: | Background : The use of biomarkers in basic and clinical research as well as in clinical practice has become so common that their presence as primary endpoints in clinical trials is now accepted. A biomarker refers to a broad subcategory of medical signs. The aims of this article are to consider the of use biomarkers in Mild stages of Alzheimer’s disease (AD) in research and clinical settings, in addition to defining their utility in clinical practice relating this with nutritional and lifestyle factors as possible treatment. Methods : We searched MEDLINE, PubMed, and AgeLine databases using different keywords. Conclusions : A summary of the utility of biomarkers in AD and nutritional and lifestyle factors used as treatment in mild stages are described. Key words : Biomarkers, Alzheimer’s disease , Dementia, Utility, Clinical practice, Nutritional |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|